NASDAQ:HEPA

Hepion Pharmaceuticals Stock News

Healthcare > Biotechnology

Buy HEPA

*Your capital is at risk

$0.0600

-0.0030 (-4.76%)

At Close: Jun 03, 2026

Why Is Hepion Pharmaceuticals (HEPA) Stock Up 68% Today?

08:19am, Monday, 22'nd May 2023

Hepion Pharmaceuticals (NASDAQ: HEPA ) stock is rising higher on Monday as the company prepares to cover clinical trial results. Hepion Pharmaceuticals is holding a conference call at 8:30 a.m.

Hepion Pharmaceuticals Schedules Conference Call to Review Topline Results from Phase 2 ‘ALTITUDE-NASH' Liver Function Trial of Rencofilstat

04:05pm, Friday, 19'th May 2023

EDISON, N.J., May 19, 2023 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic d

Hepion Pharmaceuticals to Present Data on Synergistic Effects of Rencofilstat with Anti-PD1 at AACR 2023

04:15pm, Monday, 17'th Apr 2023

EDISON, N.J., April 17, 2023 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic

10 Best-Performing Penny Stocks in the Health Care Sector

10:49pm, Monday, 03'rd Apr 2023

The healthcare sector has more high return generating companies than many other sectors.

Hepion Pharmaceuticals to Present Phase 2a Rencofilstat Multiomics Data at NASH-TAG 2023

04:15pm, Thursday, 05'th Jan 2023

EDISON, N.J., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic

Hepion Pharmaceuticals, Inc. Granted 180-day Extension by Nasdaq to Meet the Minimum Bid Price Requirements

09:30pm, Monday, 05'th Dec 2022 GlobeNewswire Inc.

EDISON, N.J., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (Nasdaq:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeuti

Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday

08:07am, Monday, 07'th Nov 2022 Benzinga

Gainers Peak Bio, Inc. (NASDAQ: PKBO) shares surged 105.8% to close at $7.82 on Friday. Peak Bio reported closing of up to $100 million common stock purchase transaction with White Lion Capital. Lade

Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session

04:54pm, Friday, 04'th Nov 2022 Benzinga

Gainers Peak Bio, Inc. (NASDAQ: PKBO) jumped 115% to $8.17. Peak Bio reported closing of up to $100 million common stock purchase transaction with White Lion Capital. Ladenburg Thalmann initiated cov

Hepion Pharmaceuticals Announces Pricing of $20.0 Million Private Placement of Convertible Redeemable Preferred Stock

12:30pm, Friday, 04'th Nov 2022 GlobeNewswire Inc.

EDISON, N.J., Nov. 04, 2022 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeuti

Hepion Pharmaceuticals Announces Publication of Food Effect Study with Rencofilstat

08:30pm, Thursday, 20'th Oct 2022 GlobeNewswire Inc.

EDISON, N.J., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeuti

Hepion Pharmaceuticals to Participate in the Cantor Oncology, Hematology & HemeOnc Conference

09:00pm, Monday, 26'th Sep 2022 GlobeNewswire Inc.

EDISON, N.J., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeut

Upcoming Presentation at Joint Meeting of ISBRA and ESBRA to Highlight Potential of Hepion Pharmaceutical’s Rencofilstat to Treat Alcohol-Related Liver Disease

12:00pm, Wednesday, 14'th Sep 2022 GlobeNewswire Inc.

EDISON, N.J., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeut

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by